Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Brain Stem Neoplasms, Primary: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Brain Stem Neoplasms, Primary: 1 US clinical trial tracked, none currently recruiting.

Brain Stem Neoplasms, Primary is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, running 1 of these trials.

Enrollment posture brief

Registry condition brain-stem-neoplasms-primary

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Brain Stem Neoplasms, Pr (th…0%
Open-enrollment share among volume-matched conditions near Brain Stem Neoplasms, Primary

Brain Stem Neoplasms, Primary has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Brain Stem Neoplasms, Primary on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Brain Stem Neoplasms, Primary is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Brain Stem Neoplasms, Primary records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

External Beam Radiation Therapy Procedure
1 trials
Thalomid Drug
1 trials
Carboplatin Drug
1 trials

US sites by state

Facility locations filed on Brain Stem Neoplasms, Primary trials. A trial with sites in several states counts in each.

Ohio 1 trials
Missouri 1 trials
Minnesota 1 trials
Illinois 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Brain Stem Neoplasms, Primary page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Brain Stem Neoplasms, Primary condition card totals 1 registered trials; most-linked intervention External Beam Radiation Therapy; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.